1-[(7-HYDROXY-2-OXO-2H-CHROMEN-4-YL)-METHYL]-6-CHLORO-PURINE
Compound with spectra: 1 NMR
![1-[(7-HYDROXY-2-OXO-2H-CHROMEN-4-YL)-METHYL]-6-CHLORO-PURINE](/api/compound/JXLJk30dLrI.png?ph=true&h=300&w=458 "1-[(7-HYDROXY-2-OXO-2H-CHROMEN-4-YL)-METHYL]-6-CHLORO-PURINE")
| SpectraBase Compound ID | JXLJk30dLrI |
|---|---|
| InChI | InChI=1S/C15H9ClN4O3/c16-14-13-15(18-6-17-14)20(7-19-13)5-8-3-12(22)23-11-4-9(21)1-2-10(8)11/h1-4,6-7,21H,5H2 |
| InChIKey | XFCJCHAYDQMQTE-UHFFFAOYSA-N |
| Mol Weight | 328.72 g/mol |
| Molecular Formula | C15H9ClN4O3 |
| Exact Mass | 328.036318 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-[(7-HYDROXY-2-OXO-2H-CHROMEN-4-YL)-METHYL]-PURINE
1-[(7-HYDROXY-2-OXO-2H-CHROMEN-4-YL)-METHYL]-2-AMINO-PURINE
2-[2-OXO-7-[[4-OXO-2-STYRYL-THIAZOLIDIN-3-YLCARBAMOYL]-METHOXY]-2H-CHROMEN-4-YL]-N-(4-OXO-2-STYLYL-THIAZOLIDIN-3-YL)-ACETAMIDE
2-furancarboxylic acid, 5-[[(2-oxo-4-phenyl-6-propyl-2H-1-benzopyran-7-yl)oxy]methyl]-, methyl ester
4-((4-(((1H-benzo[d]imidazol-2-yl)thio)methyl)-1H-1,2,3-triazol-1-yl)methyl)-2H-benzo[g]chromen-2-one
4-((4-(((1H-benzo[d]imidazol-2-yl)thio)methyl)-1H-1,2,3-triazol-1-yl)methyl)-7,8-dimethyl-2H-chromen-2-one
ethyl 4-(4-methoxyphenyl)-2-({[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}amino)-3-thiophenecarboxylate
2-(4-METHYL-2-OXO-2H-CHROMEN-7-YLOXY)-N-[4-OXO-2-(3-PHENOXYPHENYL)-THIAZOLIDIN-3-YL]-ACETAMIDE
2H-1-benzopyran-3-propanamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-methyl-7-[(2-methyl-2-propenyl)oxy]-2-oxo-
2-[(p-Hydroxycarbonyl)phenylamino]-3-[(4'-methylcoumarin-7'-yl)oxy]-quinoxaline
| Title | Journal or Book | Year |
|---|---|---|
| Novel Coumarin Derivatives Containing 1,2,4-Triazole, 4,5-Dicyanoimidazole and Purine Moieties: Synthesis and Evaluation of Their Cytostatic Activity | Molecules | 2012 |